Abstract
New ligands 5-((4-(3-(pyridine-4-yl)-7H-[1,2,4]triazolo[3,4-b] [1, 3,4]thiadiazine-6-yl)phenylamino)methyl)quinolin-8-ol (L1) and 5-((3-(pyridine-4-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine-6- ylamino)methyl)quinolin-8-ol (L2) have been synthesized. The obtained ligands were characterized by 1H NMR, 13C NMR, and IR spectroscopic techniques, and reacted with transition metal salts to afford metal containing heterochelates. The structures of the synthesized heterochelates were characterized using elemental analyses, infrared spectra, electronic spectra, magnetic measurements, FAB mass spectrum, and thermo gravimetric analyses. The kinetic parameters, such as order of reaction (n) and the energy of activation (Ea), are reported using the Freeman–Carroll method. Ligands and heterochelates were also screened for their in vitro antibacterial activity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Synthesis and Reactivity in Inorganic, Metal-Organic, and Nano-Metal Chemistry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
